About US
Contact us
-
Pre-chemo nod for Medivation's Xtandi sets up showdown with J&J's ZytigaJohnson & Johnson's ($JNJ) next-gen prostate cancer pill,Zytiga, has been cruising since it hit the market back in April 2011, but now, it may be vulnerable to market share losses for the first ti2014/9/12
-
GSK partners with UK and South African research councils for NCDs in AfricaBritish drug-maker GlaxoSmithKline (GSK) has partnered with UK and South African medical research councils (MRC) to carry out research on non-communicable diseases (NCDs) in Africa. The £5m col2014/9/11
-
FDA grants approval for Keryx’s ferric citrate to treat dialysis patients with hyperphosphatemiaKeryx Biopharmaceuticals has received approval from the US Food and Drug Administration (FDA) for its ferric citrate (formerly known as Zerenex), a new oral iron-based treatment for dialysis patients2014/9/11
-
The pressure's on Novo's marketing force as FDA nod for liraglutide nearsNovo Nordisk ($NVO) may be nearing the regulatory finish line with an obesity-fighting dose of liraglutide, up for debate by the FDA's advisers this week. But as its struggling rivals can attest, when2014/9/10
-
Judge: Merck must fight claims that it lied about mumps vaccine benefitsMerck ($MRK) tried to block two lawsuits claiming it lied about the efficacy of its mumps vaccine--but the pharma giant couldn't stop them. A federal judge in Pennsylvania refused to dismiss the lawsu2014/9/9
-
The top 10 best-selling multiple sclerosis drugs of 2013Want a surefire way to shake up a drug market? Introduce new medication options that make it easier for patients to manage their disease. MS drugmakers would know; their market is all of a sudden full2014/9/5
-
FDA clears sNDA for UCB’s Vimpat anti-epileptic drug as monotherapyThe US Food and Drug Administration (FDA) has cleared a supplemental new drug application (sNDA) for UCB's Vimpat (lacosamide) C-V as montherapy to treat partial-onset seizures in patients with epilep2014/9/4
-
Indian Excipients Industry Partner to Set Up IPEC IndiaIndia's leading names in pharmaceutical excipients are joining forces to set up its first ever excipients council. The founding members of IPEC India are Mr Ajit Singh of ACG Worldwide and Mr Subodh2014/9/4
-
FDA clears GSK’s Promacta sNDA to treat SAA patientsThe US Food and Drug Administration (FDA) has given its clearance to supplemental new drug application (sNDA) for GlaxoSmithKline's (GSK) Promacta (eltrombopag) to treat patients with severe aplastic2014/9/3
-
Pfizer and Protalix’s Elelyso receives FDA approval to treat type 1 Gaucher diseasePfizer and Protalix BioTherapeutics have secured approval from the US Food and Drug Administration (FDA) for Elelyso (taliglucerase alfa) to treat paediatric patients with type 1 Gaucher disease. Ele2014/9/2